Task: Answer the MCQ question.
Query: Which drug exhibits a -34.420\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a CC(C)C(NC(=O)OCc1ccccc1)C(=O)NCc1ccc(C(=O)O)cc1
b C/C(=N\NC(=O)c1nnn(-c2nonc2N)c1-c1cccs1)c1ccc(C)cc1
c CC1CCCC(N2CCN(C(=O)c3ccc([N+](=O)[O-])cc3)CC2)C1.O=C(O)C(=O)O
d Cc1cc(C)c(C)c(S(=O)(=O)Nc2ccccc2C(=O)NCCCN2CCOCC2)c1C
Answer: d. Cc1cc(C)c(C)c(S(=O)(=O)Nc2ccccc2C(=O)NCCCN2CCOCC2)c1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(C)c(C)c(S(=O)(=O)Nc2ccccc2C(=O)NCCCN2CCOCC2)c1C
Cc1cc(C)c(C)c(S(=O)(=O)Nc2ccccc2C(=O)NCCCN2CCOCC2)c1C
N-(3-morpholin-4-ylpropyl)-2-[(2,3,5,6-tetramethylphenyl)sulfonylamino]benzamide